These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Experiences after long-term treatment of a type I Gaucher disease patient with liposome-entrapped glucocerebroside: beta-glucosidase. Gregoriadis G; Neerunjun D; Meade TW; Goolamali SK; Weereratne H; Bull G Birth Defects Orig Artic Ser; 1980; 16(1):383-92. PubMed ID: 6778529 [No Abstract] [Full Text] [Related]
3. Liposomes in Gaucher type I disease: use in enzyme therapy and the creation of an animal model. Gregoriadis G; Weereratne H; Blair H; Bull GM Prog Clin Biol Res; 1982; 95():681-701. PubMed ID: 6812092 [No Abstract] [Full Text] [Related]
4. Status of enzyme replacement therapy for Gaucher disease. Brady RO; Barranger JA; Gal AE; Pentchev PG; Furbish FS Birth Defects Orig Artic Ser; 1980; 16(1):361-8. PubMed ID: 7004519 [TBL] [Abstract][Full Text] [Related]
5. [Gaucher's disease: results of enzymatic treatment with beta glucosidase acid]. Genovés Terol I; Martínez Porcal C; Ferrrer Lorente B; Menor Serrano F; Dalmau Serra J An Esp Pediatr; 1997 Apr; 46(4):406-8. PubMed ID: 9214240 [No Abstract] [Full Text] [Related]
11. Clinical and enzyme studies in Gaucher disease. Kaur M; Kabra M; Kher A; Naik G; Bharucha BA; Verma IC Indian Pediatr; 1996 Sep; 33(9):735-8. PubMed ID: 9057400 [TBL] [Abstract][Full Text] [Related]
12. [Type I Gaucher's disease: presentation of a case with a 12-year course]. Nevado M; Eizaguirre B; López JI; Ibáñez T Sangre (Barc); 1989 Oct; 34(5):382. PubMed ID: 2617392 [No Abstract] [Full Text] [Related]
13. The beta-glucosidase isozymes and the enzymatic defect in Gaucher disease. Patrick AD Prog Clin Biol Res; 1982; 95():287-308. PubMed ID: 6812075 [No Abstract] [Full Text] [Related]
14. Attempt at enzyme replacement in Gaucher disease by renal transplantation. Groth CG; Collste H; Dreborg S; Håkansson G; Lundgren G; Svennerholm L Birth Defects Orig Artic Ser; 1980; 16(1):475-90. PubMed ID: 6778533 [No Abstract] [Full Text] [Related]
15. Liposomes in therapeutic and preventive medicine: the development of the drug-carrier concept. Gregoriadis G Ann N Y Acad Sci; 1978; 308():343-70. PubMed ID: 100040 [No Abstract] [Full Text] [Related]
16. Gaucher disease: a century of delineation and research. Enzyme replacement therapy: model and clinical studies. Beutler E; Dale GL Prog Clin Biol Res; 1982; 95():703-16. PubMed ID: 7122644 [TBL] [Abstract][Full Text] [Related]
17. Multiple forms of beta-glucosidase in Gaucher disease. Yaqoob M; Carroll M Prog Clin Biol Res; 1982; 95():453-63. PubMed ID: 6812081 [No Abstract] [Full Text] [Related]
18. Glucosylceramide and related compounds in normal tissues and in Gaucher disease. Suzuki K Prog Clin Biol Res; 1982; 95():219-30. PubMed ID: 7122635 [No Abstract] [Full Text] [Related]
19. Effectors of three beta-glucosidases from human liver. Daniels LB; Gnarra JR; Glew RH Prog Clin Biol Res; 1982; 95():333-55. PubMed ID: 6812077 [TBL] [Abstract][Full Text] [Related]
20. Sodium taurocholate effect on beta-glucosidase activity: a new approach for identification of Gaucher disease using the synthetic substrate and leucocytes. Magalhães J; Sá Miranda MC; Pinto R; Lemos M; Poenaru L Clin Chim Acta; 1984 Aug; 141(2-3):111-8. PubMed ID: 6435915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]